Search results
King Charles set for return to public duty as Harry plans solo visit to UK: Live
The Independent via Yahoo News· 2 hours agoThe 75-year-old British monarch will slowly ease back into public life after a three-month break to...
King Charles III resumes public duties as he fights cancer
AFP via Yahoo News· 4 hours agoKing Charles III on Tuesday makes his first official public appearance since being diagnosed with...
Doctors Explain What Prostate Cancer Screenings Involve
Men's Health via Yahoo News· 7 days agoWhat Prostate Cancer Screenings InvolveMorsa Images - Getty Images IF YOU’VE NEVER had a prostate...
Prince Harry Returning to the U.K. 3 Months After Visiting King Charles III - E! Online
E! Online· 15 hours agoPrince Harry is making a royally exciting return home. The 39-year-old will be heading back across...
Cancer trends revealed, including most common types of the disease and biggest risk factors
Fox News· 21 hours agoOf the 1.96 million new cancer cases in 2023, half were made up of five types: breast cancer (15%), ...
Men on hair-loss drug warned of sexual and psychiatric side effects
The Telegraph via Yahoo News· 10 hours agoIt has also ordered suppliers of finasteride to now include a patient alert card in packs of the...
Does ejaculating often reduce your risk of prostate cancer?
Medical Xpress· 5 days agoAs the prostate is a reproductive organ with its main job being to help make semen—the fluid that carries sperm in ejaculate—researchers have long questioned the effect of ...
What Is King Charles’ Funeral Plan? All the Details Inside Operation Menai Bridge
In Touch Weekly via Yahoo News· 4 days agoKing Charles III ascended to the royal throne after his mother Queen Elizabeth II's death in...
King Charles's Cancer Diagnosis and Treatment Timeline
Town & Country via Yahoo News· 4 days agoFrom his prostate surgery in January to his public appearance on Easter, here's everything we know...
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
FOX 4 Kansas City· 6 days agoXTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the ...